These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2645371)

  • 1. Direct effects of glucocorticosteroids on epidermal Langerhans cells.
    Furue M; Katz SI
    J Invest Dermatol; 1989 Mar; 92(3):342-7. PubMed ID: 2645371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
    Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
    J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 decreases the number of Ia+ epidermal dendritic cells but increases their expression of Ia antigen.
    Lundqvist EN; Bäck O
    Acta Derm Venereol; 1990; 70(5):391-4. PubMed ID: 1980971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids.
    Berman B; France DS; Martinelli GP; Hass A
    J Invest Dermatol; 1983 Mar; 80(3):168-71. PubMed ID: 6338128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of Ia-positive and Thy-1-positive leukocytes of murine epidermis.
    Romani N; Schuler G; Fritsch P
    J Invest Dermatol; 1986 Feb; 86(2):129-33. PubMed ID: 2875114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Ia+ Langerhans cell numbers in vivo by cultured epidermis derived supernatants and by GM-CSF.
    O'Sullivan GM; Sluyter R; Boswell CM; Barnetson RS; Halliday GM
    Exp Dermatol; 1996 Feb; 5(1):28-37. PubMed ID: 8624609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative lack of systemic effects of mometasone furoate on Langerhans cells of mice after topical administration as compared with other glucocorticosteroids.
    Belsito DV; Baer RL; Schultz JM; Thorbecke GJ
    J Invest Dermatol; 1988 Sep; 91(3):219-23. PubMed ID: 3166025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.
    Cooper KD; Duraiswamy N; Hammerberg C; Allen E; Kimbrough-Green C; Dillon W; Thomas D
    J Invest Dermatol; 1993 Aug; 101(2):155-63. PubMed ID: 8393901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration and maturation of Langerhans cells in skin transplants and explants.
    Larsen CP; Steinman RM; Witmer-Pack M; Hankins DF; Morris PJ; Austyn JM
    J Exp Med; 1990 Nov; 172(5):1483-93. PubMed ID: 2230654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells.
    Becker D; Reske-Kunz AB; Knop J; Reske K
    Eur J Immunol; 1991 May; 21(5):1213-20. PubMed ID: 2037010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunopharmacology; 1999 Apr; 41(3):235-43. PubMed ID: 10428652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
    Chang CH; Furue M; Tamaki K
    Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequential demonstration of non-specific esterase reactivity Ia antigen and Thy-1 antigen in murine epidermal sheets.
    Howells GL; Williams DM
    Arch Oral Biol; 1987; 32(9):679-83. PubMed ID: 2895629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products.
    Witmer-Pack MD; Valinsky J; Olivier W; Steinman RM
    J Invest Dermatol; 1988 Mar; 90(3):387-94. PubMed ID: 3279134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
    Katoh N; Hirano S; Kishimoto S; Yasuno H
    Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous reactivity of murine epidermal Langerhans cells after application of FITC: a histochemical evaluation.
    Doi S; Kobayashi M; Sugiura Y; Sakamoto T; Torii S
    Arch Histol Cytol; 1999 Oct; 62(4):363-73. PubMed ID: 10596947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.